Sharma et al., 2022 - Google Patents
Assessing periodontal health status of patients with chronic periodontitis before and after non-surgical therapy (SRP) using a BANA-Enzymatic™ test kit: A clinico …Sharma et al., 2022
View PDF- Document ID
- 13614164242806038296
- Author
- Sharma T
- Agarwal C
- Publication year
- Publication venue
- ELECTR J MED DENT STUD
External Links
Snippet
Background: There are many methods available for diagnosing and assessing periodontal health. Clinical improvements after non-surgical therapy (SRP) are directly linked to the microbiological changes, which indicates a decrease in certain periodontal microflora. The …
- 230000003239 periodontal 0 title abstract description 30
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/25—Shigella (G)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Patel et al. | Estimation and comparison of salivary calcium, phosphorous, alkaline phosphatase and pH levels in periodontal health and disease: A cross-sectional biochemical study | |
| Gupta et al. | Role of salivary matrix metalloproteinase-8 (MMP-8) in chronic periodontitis diagnosis | |
| Chaves et al. | Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy | |
| Crasta et al. | Bacteraemia due to dental flossing | |
| Bhardwaj et al. | Comparative volumetric and clinical evaluation of peri-implant sulcular fluid and gingival crevicular fluid | |
| Chapple et al. | Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels | |
| Khaira et al. | Periodontal Disease: Production of volatile sulphur compounds in diseased periodontal pockets is significantly increased in smokers | |
| Bhadbhade et al. | Correlation between probing pocket depth and neutrophil counts in dental plaque, saliva, and gingival crevicular fluid. | |
| Janska et al. | Correlation between peri-implant sulcular fluid rate and expression of collagenase2 (MMP8) | |
| Lamster et al. | Current status of tests for periodontal disease | |
| Ramenzoni et al. | Origin of MMP-8 and Lactoferrin levels from gingival crevicular fluid, salivary glands and whole saliva | |
| Durrani et al. | Myeloperoxidase level around dental implants as an indicator of an inflammatory process | |
| Nędzi-Góra et al. | The utility of gingival crevicular fluid matrix metalloproteinase-8 provides site-specific diagnostic value for periodontal grading | |
| Eick et al. | Persistence of Porphyromonas gingivalis is a negative predictor in patients with moderate to severe periodontitis after nonsurgical periodontal therapy | |
| Jud et al. | Periodontal disease and its association to endothelial dysfunction and clinical changes in limited systemic sclerosis: A case–control study | |
| Balaram et al. | Periodontal Epidemiology | |
| Levy et al. | Impact of microbiological consultation on clinical decision making: a case‐control study of clinical management of recurrent periodontitis | |
| Sharma et al. | Assessing periodontal health status of patients with chronic periodontitis before and after non-surgical therapy (SRP) using a BANA-Enzymatic™ test kit: A clinico-microbiological study | |
| Apsey et al. | The diagnosis of periodontal disease in private practice | |
| Eley et al. | Correlation of gingival crevicular fluid proteases with clinical and radiological measurements of periodontal attachment loss | |
| Tsalikis | The effect of age on the gingival crevicular fluid composition during experimental gingivitis. A pilot study | |
| Martínez-Pabón et al. | Detection of Treponema denticola in saliva obtained from patients with various periodontal conditions | |
| Menassa et al. | Periodontal diagnosis: current status and future directions | |
| Kelly | Clinical and Microbiological Evaluation of Interproximal Open Contacts and Periodontal Disease: A Cross-sectional Study | |
| Ishii et al. | Salivary leukocyte esterase activity by SillHa is a risk indicator of periodontal disease |